Top Clinical Trials companies in Hong Kong by EBT Margin
Hong Kong
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
12.60%
|
Dec. 31, 2023 | USD 2.69 | -5.38% |
|
Hong Kong |
|
| 2 |
5.61%
|
Dec. 31, 2023 | USD 0.21 | -2.31% |
|
Hong Kong |
|
| 3 |
2.92%
|
Dec. 31, 2023 | USD 0.15 | -0.79% |
|
Hong Kong |
|
| 4 |
-260.64%
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
| 5 |
-21,408.06%
|
Dec. 31, 2023 | USD 0.34 | -11.75% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest EBT Margin ?
The Clinical Trials company in Hong Kong with the highest EBT Margin is HUTCHMED (China) Limited (HKSE: 0013.HK) at 12.60%.
-
Which Clinical Trials company in Hong Kong has the lowest EBT Margin ?
The Clinical Trials company in Hong Kong with the lowest EBT Margin is Sirnaomics Ltd. (HKSE: 2257.HK) at -21,408.06%.
-
What are the top 10 Clinical Trials companies in Hong Kong by EBT Margin ?
The top 10 Clinical Trials companies in Hong Kong by EBT Margin are HUTCHMED (China) Limited, Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited, Prenetics Global Limited and Sirnaomics Ltd..
-
What are the bottom 10 Clinical Trials companies in Hong Kong by EBT Margin ?
The bottom 10 Clinical Trials companies in Hong Kong by EBT Margin are Sirnaomics Ltd., Prenetics Global Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
